Aspire Private Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-10
| Closed | -$1.16K | – | 759 |
|
2023
Q3 | $1.16K | Sell |
10
-25
| -71% | -$2.89K | ﹤0.01% | 594 |
|
2023
Q2 | $3.6K | Hold |
35
| – | – | ﹤0.01% | 489 |
|
2023
Q1 | $3.82K | Buy |
35
+10
| +40% | +$1.09K | ﹤0.01% | 475 |
|
2022
Q4 | $2.85K | Hold |
25
| – | – | ﹤0.01% | 496 |
|
2022
Q3 | $2K | Sell |
25
-7,057
| -100% | -$565K | ﹤0.01% | 540 |
|
2022
Q2 | $565K | Buy |
7,082
+158
| +2% | +$12.6K | 0.2% | 64 |
|
2022
Q1 | $728K | Buy |
6,924
+671
| +11% | +$70.6K | 0.23% | 52 |
|
2021
Q4 | $674K | Buy |
6,253
+423
| +7% | +$45.6K | 0.21% | 63 |
|
2021
Q3 | $639K | Sell |
5,830
-183
| -3% | -$20.1K | 0.21% | 56 |
|
2021
Q2 | $563K | Buy |
6,013
+1,766
| +42% | +$165K | 0.18% | 71 |
|
2021
Q1 | $391K | Buy |
+4,247
| New | +$391K | 0.14% | 77 |
|